Vertex Pharmaceuticals | VRTX - 贷款资金



金融业
股票价格
USD 498.50
资产
USD 27.42B
现金及等价物
USD 7.85B
销售成本
USD 489.2M
流动资产
USD 12.54B
流动负债
USD 3.94B
债务
USD 1.98B
EBIT
USD 1.27B
EBITDA
USD 1.33B
员工
6.1K
EPS每股收益
USD 4.73
股本和储备
USD 20.25B
销售毛利
USD 2.84B
债务利息支出
USD 3.3M
利息收入
USD 120.6M
贷款资金
USD 106.7M
市值
USD 127.89B
净收入
USD 1.1B
营业费用
USD 2.07B
营业利润
USD 1.27B
普通股股本
USD 253.3M
PE价格收益
28.05
税前利润
USD 1.39B
销售收入
USD 3.33B
销售和管理费用
USD 582.2M
股票
USD 1.77B
贸易债权人
USD 3.61B
应收帐款人
USD 2.13B


贷款资金 更改 日
AbbVie USD 64.53B 5.59B 2026-03
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.47B 6.56M 2026-06
Amgen USD 51.86B 27M 2026-06
Arrowhead Research USD 824.07M 401.34M 2026-06
Biogen USD 7.29B 1B 2026-06
BioMarin Pharmaceutical USD 3.53B 2.1B 2026-06
Bristol-Myers Squibb USD 42.09B 59M 2026-06
Gilead Sciences USD 20.86B 1.27B 2026-03
Incyte USD 28.42M 994K 2026-06
Insmed USD 543.51M 1.3M 2026-06
Ionis Pharmaceuticals USD 1.91B 6.62M 2026-06
J&J USD 37.34B 183M 2026-06
Merck USD 51.08B 4.41B 2026-06
Moderna USD 597M 6M 2026-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 37.49B 42M 2026-06
Pfizer USD 60.5B 70M 2026-06
PTC Therapeutics USD 535.52M 248.58M 2026-06
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 1.99B 400K 2026-06
Roche Holding CHF 25.22B 2.21B 2026-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 14.65B 806M 2026-06
Sarepta Therapeutics USD 847.62M 9.46M 2026-06
Ultragenyx Pharmaceutical USD 1.13B 19M 2026-03
United Therapeutics USD 100M 100M 2024-06
Vertex Pharmaceuticals USD 106.7M 4.7M 2025-12